The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Changing incidence of non‐Hodgkin lymphomas in the United States
Abstract
BACKGROUND: The incidence of non‐Hodgkin lymphoma (NHL) has been rising in many regions and populations during the last few decades. Data from the Surveillance, Epidemiology, and End Results (SEER) Program show that age‐adjusted rates of NHL increased through the 1980s but leveled off in the 1990s. METHODS: To determine whether the incidence of NHL stabilized in all population subgroups, particularly in age‐defined groups with distinctive risks of NHL, the authors investigated trends in NHL incidence among persons aged 0–14 years, 15–24 years, 25–34 years, 35–44 years, 45–54 years, 55–64 years, 65–74 years, and > 75 years by gender and race using 1973–1998 data from the SEER Program, which covered approximately 10% of the U.S. population. Joinpoint regression was used to assess changes in trends across the period. RESULTS: NHL incidence trends changed significantly among males aged 25–54 years, in whom rates began to decrease (6–16% per year) in the middle to late 1990s, as well as among most whites aged ≥ 55 years, in whom rate increases slowed from 3–4% to 1–2% per year in the late 1980s. Incidence trends were steady in other groups, with uniform increases among whites aged 15–24 years (2–3% per year), women aged 25–54 years (1–6% per year), and blacks aged ≥ 55 years (2–4% per year). Although recent age specific incidence rates were generally higher in males compared with females and in whites compared with blacks, among males aged 25–54 years, rates were significantly higher in black males compared with white males. CONCLUSIONS: There have been changes in the demographic groups impacted by NHL. The trends for human immunodeficiency virus probably are related to recent decreases in NHL incidence among males aged 25–54 years. The rate change in the older white population is unexplained but represents both an alleviation of the burden of NHL in this population and a potential opportunity to generate hypotheses regarding risk factors for the development of NHL. Cancer 2002;94:2015–23. © 2002 American Cancer Society. DOI 10.1002/cncr.10403
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diabetes trends in the U.S.: 1990-1998.
Mokdad, A. H., Ford, E. S., Bowman, B. A., Nelson, D. E., Engelgau, M. M., Vinicor, F., & Marks, J. S. (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1278 · Cited by 1,042
Cited by
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001
Morton, L. M., Wang, S. S., Devesa, S. S., Hartge, P., Weisenburger, D. D., & Linet, M. S. (2006) · Blood · doi:10.1182/blood-2005-06-2508 · Cited by 1,683
Armitage, J. O., Gascoyne, R. D., Lunning, M. A., & Cavalli, F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32407-2 · Cited by 1,176
2016 US lymphoid malignancy statistics by World Health Organization subtypes
Teras, L. R., DeSantis, C. E., Cerhan, J. R., Morton, L. M., Jemal, A., & Flowers, C. R. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21357 · Cited by 1,125
Espey, D. K., Wu, X., Swan, J., Wiggins, C., Jim, M. A., Ward, E., Wingo, P. A., Howe, H. L., Ries, L. A. G., Miller, B. A., et al. (2007) · Cancer · doi:10.1002/cncr.23044 · Cited by 576
Theander, E., Henriksson, G., Ljungberg, O., Mandl, T., Manthorpe, R., & Jacobsson, L. T. H. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.041186 · Cited by 574
Metadata
- Authors
- Clarke, C. A., & Glaser, S. L.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2002-03-28
- Volume
- 94
- Issue
- 7
- Pages
- 2015-2023
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1982666749
- Cited by
- 173
- References
- 1
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changing incidence of non‐Hodgkin lymphomas in the United States. https://app.cochat.ai/papers/10.1002/cncr.10403
- The paper
- Clarke, C. A., & Glaser, S. L. (2002). Changing incidence of non‐Hodgkin lymphomas in the United States. Cancer. https://doi.org/10.1002/cncr.10403
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.